You are using an older browser version. Please use a supported version for the best MSN experience.

Two Excedrin products are temporarily discontinued, company says

CNN logo CNN 1/22/2020 By Faith Karimi, CNN

a close up of a bottle: **FILE** Excedrin pain medication from Bristol-Myers Squibb is shown in this July 27, 2006 file photo in New York.  Drug developer Bristol-Myers Squibb Co. said on Thursday, Oct. 25, 2007 its third-quarter profit more than doubled on a surge in sales of its blood thinner Plavix, and raised its outlook for adjusted 2007 earnings. (AP Photo/Mark Lennihan, file) © Mark Lennihan/AP **FILE** Excedrin pain medication from Bristol-Myers Squibb is shown in this July 27, 2006 file photo in New York. Drug developer Bristol-Myers Squibb Co. said on Thursday, Oct. 25, 2007 its third-quarter profit more than doubled on a surge in sales of its blood thinner Plavix, and raised its outlook for adjusted 2007 earnings. (AP Photo/Mark Lennihan, file) Pharmaceutical company GlaxoSmithKline says it has temporarily discontinued two types of Excedrin items as a precautionary measure.

The company has suspended production and distribution of its Excedrin Extra Strength and Excedrin Migraine products, it said.

"Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs," it said in a statement to CNN.

The company does not believe that the product poses a safety risk to consumers but has voluntarily implemented the measure as a precaution, it said.

"We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume," it said. "Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product."

GlaxoSmithKline described it as a short term issue, saying it expects production to resume shortly.

AdChoices
AdChoices

More From CNN

image beaconimage beaconimage beacon